93
Views
0
CrossRef citations to date
0
Altmetric
Review

Current Status of Distal Embolization in Percutaneous Coronary Intervention: Mechanical and Pharmacological Strategies

, , &
Pages 385-402 | Published online: 06 Aug 2009

  • Keeley EC , BouraJA, GrinesCL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.Lancet, 361(9351), 13–20 (2003).
  • Henriques JP , ZijlstraF: Frequency and sequelae of ST elevation acute myocardial infarction caused by spontaneous distal embolization from unstable coronary lesions.Am. J. Cardiol., 91(6), 708–711 (2003).
  • Rezkalla SH , KlonerRA: No-reflow phenomenon.Circulation, 105(5), 656–662 (2002).
  • Kloner RA , RudeRE, CarlsonNet al.: Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first?Circulation, 62(5), 945–952 (1980).
  • van Gaal WJ , BanningAP: Percutaneous coronary intervention and the no-reflow phenomenon.Expert. Rev. Cardiovasc. Ther., 5(4), 715–731 (2007).
  • Ito H : No-reflow phenomenon and prognosis in patients with acute myocardial infarction.Nat. Clin. Pract. Cardiovasc. Med., 3(9), 499–506 (2006).
  • Kotani J , NantoS, MintzGSet al.: Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome.Circulation, 106(13), 1672–1677 (2002).
  • Henriques JP , ZijlstraF, OttervangerJPet al.: Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction.Eur. Heart J., 23(14), 1112–1117 (2002).
  • Fokkema ML , VlaarPJ, SvilaasTet al.: Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction.Eur. Heart J., 30(8), 908–915 (2009).
  • Napodano M , RamondoA, TarantiniGet al.: Predictors and time-related impact of distal embolization during primary angioplasty.Eur. Heart J., 30(3), 305–313 (2009).
  • Sianos G , PapafaklisMI, DaemenJet al.: Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden.J. Am. Coll. Cardiol., 50(7), 573–583 (2007).
  • Hiscock M , OqueliE, DickR: Percutaneous saphenous vein graft intervention – a review.Heart Lung Circ., 16(Suppl. 3), S51–S55 (2007).
  • Webb JG , CarereRG, VirmaniRet al.: Retrieval and analysis of particulate debris after saphenous vein graft intervention.J. Am. Coll. Cardiol., 34(2), 468–475 (1999).
  • Coolong A , BaimDS, KuntzREet al.: Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients.Circulation, 117(6), 790–797 (2008).
  • Okamura A , ItoH, IwakuraKet al.: Detection of embolic particles with the Doppler guide wire during coronary intervention in patients with acute myocardial infarction: efficacy of distal protection device.J. Am. Coll. Cardiol., 45(2), 212–215 (2005).
  • Buller CE , FuY, MahaffeyKWet al.: ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.Circulation, 118(13), 1335–1346 (2008).
  • McLaughlin MG , StoneGW, AymongEet al.: Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.J. Am. Coll. Cardiol., 44(6), 1215–1223 (2004).
  • Moons KG , KlootwijkP, MeijSHet al.: Continuous ST-segment monitoring associated with infarct size and left ventricular function in the GUSTO-I trial.Am. Heart J., 138(3 Pt 1), 525–532 (1999).
  • van ‘t Hof AW , LiemA, de Boer MJ, Zijlstra F: Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group. Lancet, 350(9078), 615–619 (1997).
  • Judd RM , Lugo-OlivieriCH, AraiMet al.: Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts.Circulation, 92(7), 1902–1910 (1995).
  • Hirsch A , NijveldtR, HaeckJDet al.: Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction.J. Am. Coll. Cardiol., 51(23), 2230–2238 (2008).
  • Nijveldt R , BeekAM, HirschAet al.: Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury.J. Am. Coll. Cardiol., 52(3), 181–189 (2008).
  • Silber S , AlbertssonP, AvilesFFet al.: Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.Eur. Heart J., 26(8), 804–847 (2005).
  • Smith SC et al. Jr, Feldman TE, Hirshfeld JW Jr : ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention – summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation, 113(1), 156–175 (2006).
  • Gibson CM , ZorkunC, KunadianV: Intracoronary administration of abciximab in ST-elevation myocardial infarction.Circulation, 118(1), 6–8 (2008).
  • Lee KW , NorellMS: Management of ‘no-reflow‘ complicating reperfusion therapy.Acute. Card Care, 10(1), 5–14 (2008).
  • Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators: Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet, 367(9510), 569–578 (2006).
  • Ellis SG , TenderaMet al., de Belder MA : Facilitated PCI in patients with ST-elevation myocardial infarction. N. Engl. J. Med., 358(21), 2205–2217 (2008).
  • Mehilli J , KastratiA, SchulzSet al.: Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial.Circulation, 119(14), 1933–1940 (2009).
  • Matsuo A , InoueN, SuzukiKet al.: Limitations of using a GuardWire temporary occlusion and aspiration system in patients with acute myocardial infarction: multicenter investigation of coronary artery protection with a distal occlusion device in acute myocardial infarction (MICADO).J. Invasive Cardiol., 19(3), 132–138 (2007).
  • Muramatsu T , KozumaK, TsukaharaRet al.: Comparison of myocardial perfusion by distal protection before and after primary stenting for acute myocardial infarction: Angiographic and clinical results of a randomized controlled trial.Catheter. Cardiovasc. Interv., 70(5), 677–682 (2007).
  • Stone GW , WebbJ, CoxDAet al.: Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial.JAMA, 293(9), 1063–1072 (2005).
  • Tahk SJ , ChoiBJ, ChoiSYet al.: Distal protection device protects microvascular integrity during primary percutaneous intervention in acute myocardial infarction: a prospective, randomized, multicenter trial.Int. J. Cardiol., 123(2), 162–168 (2007).
  • Gick M , JanderN, BestehornHPet al.: Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation.Circulation, 112(10), 1462–1469 (2005).
  • Kelbaek H , TerkelsenCJ, HelqvistSet al.: Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial.J. Am. Coll. Cardiol., 51(9), 899–905 (2008).
  • Koch KT , HaeckJDet al., van der Schaaf RJ : Proximal embolic protection with aspiration in percutaneous corononary intervention using the proxistrade mark device. Rev. Cardiovasc. Med., 8(3), 160–166 (2007).
  • Haeck JD , KochKT, BilodeauLet al.: Randomized comparison of primary percutaneous coronary intervention with combined proximal embolic protection and thrombus aspiration and primary percutaneous coronary intervention alone in ST-segment elevation myocardial infarction. Presented at the American College of Cardiology and i2 Summit 2009, Orlando.J. Am. Coll. Cardiol. Suppl., A-28, 2612–2619 (2009).
  • Ali A , CoxD, DibNet al.: Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study.J. Am. Coll. Cardiol., 48(2), 244–252 (2006).
  • Antoniucci D , ValentiR, MiglioriniAet al.: Comparison of rheolytic thrombectomy before direct infarct artery stenting versus direct stenting alone in patients undergoing percutaneous coronary intervention for acute myocardial infarction.Am. J. Cardiol., 93(8), 1033–1035 (2004).
  • Beran G , LangI, SchreiberWet al.: Intracoronary thrombectomy with the X-sizer catheter system improves epicardial flow and accelerates ST-segment resolution in patients with acute coronary syndrome: a prospective, randomized, controlled study.Circulation, 105(20), 2355–2360 (2002).
  • Lefevre T , GarciaE, ReimersBet al.: X-sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution: results of the X-sizer in AMI for negligible embolization and optimal ST resolution (X AMINE ST) trial.J. Am. Coll. Cardiol., 46(2), 246–252 (2005).
  • Napodano M , PasquettoG, SaccaSet al.: Intracoronary thrombectomy improves myocardial reperfusion in patients undergoing direct angioplasty for acute myocardial infarction.J. Am. Coll. Cardiol., 42(8), 1395–1402 (2003).
  • De Carlo M , WoodDA, WebbJGet al.: Adjunctive use of the Rinspiration system for fluidic thrombectomy during primary angioplasty: the Rinspiration international registry.Catheter. Cardiovasc. Interv., 72(2), 196–203 (2008).
  • Burzotta F , TraniC, RomagnoliEet al.: Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial.J. Am. Coll. Cardiol., 46(2), 371–376 (2005).
  • De Luca L , SardellaG, DavidsonCJet al.: Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodelling in patients with anterior ST elevation myocardial infarction.Heart, 92(7), 951–957 (2006).
  • Silva-Orrego P , ColomboP, BigiRet al.: Thrombus aspiration before primary angioplasty improves myocardial reperfusion in acute myocardial infarction: the DEAR-MI (Dethrombosis to Enhance Acute Reperfusion in Myocardial Infarction) study.J. Am. Coll. Cardiol., 48(8), 1552–1559 (2006).
  • Kaltoft A , BottcherM, NielsenSSet al.: Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial.Circulation, 114(1), 40–47 (2006).
  • Ikari Y , SakuradaM, KozumaKet al.: Upfront thrombus aspiration in primary coronary intervention for patients with ST-segment elevation acute myocardial infarction: report of the VAMPIRE (VAcuuM asPIration thrombus REmoval) trial.JACC Cardiovasc. Interv., 1(4), 424–431 (2008).
  • Svilaas T , VlaarPJet al., van der Horst, I : Thrombus aspiration during primary percutaneous coronary intervention. N. Engl. J. Med., 358(6), 557–567 (2008).
  • Vlaar PJ , SvilaasTet al., van der Horst I : Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet, 371(9628), 1915–1920 (2008).
  • Sardella G , ManconeM, Bucciarelli-DucciCet al.: Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial.J. Am. Coll. Cardiol., 53(4), 309–315 (2009).
  • De Luca G , DudekD, SardellaG, MarinoP, ChevalierB, ZijlstraF: Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials.Eur. Heart J., 29(24), 3002–3010 (2008).
  • De Luca G , SuryapranataH, StoneGWet al.: Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.JAMA, 293(14), 1759–1765 (2005).
  • Montalescot G , AntoniucciD, KastratiAet al.: Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients‘ data with long-term follow-up.Eur. Heart J., 28(4), 443–449 (2007).
  • De Luca G , UcciG, CassettiE, MarinoP: Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-analysis.J. Am. Coll. Cardiol., 53(18), 1668–1673 (2009).
  • Thiele H , SchindlerK, FriedenbergerJet al.: Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.Circulation, 118(1), 49–57 (2008).
  • Sezer M , OflazH, GorenTet al.: Intracoronary streptokinase after primary percutaneous coronary intervention.N. Engl. J. Med., 356(18), 1823–1834 (2007).
  • Hong MK , MehranR, DangasGet al.: Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality.Circulation, 100(24), 2400–2405 (1999).
  • Baim DS , WahrD, GeorgeBet al.: Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts.Circulation, 105(11), 1285–1290 (2002).
  • Stone GW , RogersC, HermillerJet al.: Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts.Circulation, 108(5), 548–553 (2003).
  • Carrozza JP Jr, Mumma M, Breall JA, Fernandez A, Heyman E, Metzger C: Randomized evaluation of the TriActiv balloon-protection flush and extraction system for the treatment of saphenous vein graft disease. J. Am. Coll. Cardiol., 46(9), 1677–1683 (2005).
  • Mauri L , CoxD, HermillerJet al.: The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial.J. Am. Coll. Cardiol., 50(15), 1442–1449 (2007).
  • Kereiakes DJ , TurcoMA, BreallJet al.: A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial.JACC Cardiovasc. Interv., 1(3), 248–257 (2008).
  • Roffi M , MukherjeeD, ChewDPet al.: Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials.Circulation, 106(24), 3063–3067 (2002).
  • Topol EJ , YadavJS: Recognition of the importance of embolization in atherosclerotic vascular disease.Circulation, 101(5), 570–580 (2000).
  • Michaels AD , ApplebyM, OttenMHet al.: Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial.J. Invasive Cardiol., 14(6), 299–302 (2002).
  • Stone GW , WitzenbichlerB, GuagliumiGet al.: Bivalirudin during primary PCI in acute myocardial infarction.N. Engl. J. Med., 358(21), 2218–2230 (2008).
  • Wiviott SD , BraunwaldE, McCabeCHet al.: Prasugrel versus clopidogrel in patients with acute coronary syndromes.N. Engl. J. Med., 357(20), 2001–2015 (2007).
  • Cura FA , EscuderoAG, BerrocalDet al.: Protection of Distal Embolization in High-Risk Patients with Acute ST-Segment Elevation Myocardial Infarction (PREMIAR).Am. J. Cardiol., 99(3), 357–363 (2007).
  • Dudek D , MieleckiW, LegutkoJet al.: Percutaneous thrombectomy with the RESCUE system in acute myocardial infarction.Kardiol. Pol., 61(12), 523–533 (2004).
  • De Luca L , SardellaG, DavidsonCJet al.: Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodelling in patients with anterior ST elevation myocardial infarction.Heart, 92(7), 951–957 (2006).
  • Chevalier B , GilardM, LangIet al.: Systematic primary aspiration in acute myocardial percutaneous intervention: a multicentre randomised controlled trial of the export aspiration catheter.EuroIntervention, 4(2), 222–228 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.